Average Co-Inventor Count = 4.64
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck + Co., Inc. (44 from 4,770 patents)
2. Merck Sharp + Dohme Corp. (41 from 2,405 patents)
3. Msd Italia S.r.l. (4 from 7 patents)
4. Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa (2 from 47 patents)
5. Other (1 from 832,880 patents)
6. Addex Pharma, S.a. (1 from 37 patents)
7. Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.r.l. (1 from 4 patents)
8. Insituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa (1 from 1 patent)
9. Merck Canada Inc. (40 patents)
86 patents:
1. 11655216 - Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use
2. 10961215 - N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their use
3. 10894775 - Piperidine derivatives as liver X receptor beta agonists, compositions, and their use
4. 10526336 - Fused heteroaryl derivatives as orexin receptor antagonists
5. 10435398 - Oxazole orexin receptor antagonists
6. 10308645 - Piperidine oxadiazole and thiadiazole orexin receptor antagonists
7. 10239838 - Heteroaryl orexin receptor antagonists
8. 10227336 - Pyrazole orexin receptor antagonists
9. 10214535 - Hydroxmethyl piperidine orexin receptor antagonists
10. 10155750 - Amidoethyl azole orexin receptor antagonists
11. 10150751 - Pyrrolidine orexin receptor antagonists
12. 10017504 - Piperidine isoxazole and isothiazole orexin receptor antagonists
13. 10011595 - Ethyldiamine orexin receptor antagonists
14. 10010539 - Pyrazole, triazole and tetrazole orexin receptor antagonists
15. 9987255 - 5,5-bicyclic oxazole orexin receptor antagonists